未登录.png)
分享.png)
收藏A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries
Belkacemi, Yazid; Grellier, Noemie; Ghith, Sahar; Debbi, Kamel; Coraggio, Gabriele; Bounedjar, Adda; Samlali, Redouane; Tsoutsou, Pauletta G.; Ozsahin, Mahmut; Chauvet, Marie -Pierre; Turkan, Sedat; Boussen, Hamouda; Kuten, Abraham; Tesanovic, Dusanka; Errihani, Hassan; Benna, Farouk; Bouzid, Kamel; Idbaih, Ahmed; Mokhtari, Karima; Popovic, Lazar; Spano, Jean-Philippe; Lotz, Jean-Pierre; Cherif, Aziz; To, Hahn; Kovcin, Vladimir; Arsovski, Oliver; Beslija, Semir; Dzodic, Radan; Markovic, Ivan; Vasovic, Suzana; Stamatovic, Liljana; Radosavljevic, Davorin; Radulovic, Sinisa; Vrbanec, Damir; Sahraoui, Souha; Vasev, Nino; Stojkovski, Igor; Risteski, Milan; Freixa, Salvador Villa; Krengli, Marco; Radosevic, Nina; Mustacchi, Giorgio; Filipovic, Mladen; Kerrou, Khaldoun; Taghian, Alphonse G.; Todorovic, Vladimir; Geara, Fady; Gligorov, Joseph 分享 收藏 分享 收藏 Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancerZielinski, Christoph; Lang, Istvan; Beslija, Semir; Kahan, Zsuzsanna; Inbar, Moshe J.; Stemmer, Salomon M.; Anghel, Rodica; Vrbanec, Damir; Messinger, Diethelm; Brodowicz, Thomas 分享 收藏 FOLFOX4 Plus Cetuximab for Patients With Previously Untreated Metastatic Colorectal Cancer According to Tumor RAS and BRAF Mutation Status: Updated Analysis of the CECOG/CORE 1.2.002 StudyKaczirek, Klaus; Ciuleanu, Tudor E.; Vrbanec, Damir; Marton, Erika; Messinger, Diethelm; Liegl-Atzwanger, Bernadette; Wrba, Fritz; Knittelfelder, Regina; Lindner, Elisabeth; Zielinski, Christoph C.; Streubel, Berthold; Brodowicz, Thomas 分享 收藏 Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK IntergroupRordorf, Tamara; Hassan, Azza Adel; Azim, Hamdy; Alexandru, Eniu; Er, Ozlem; Gokmen, Erhan; Gural, Zeynep; Mardiak, Jozef; Minchev, Velko; Peintinger, Florentia; Szendroi, Miklos; Takac, Itzok; Tesarova, Petra; Vorobiof, Daniel; Vrbanec, Damir; Yildiz, Ramazan; Yucel, Serap; Zekri, Jamal; Oyan, Basak 分享 收藏 Delays in diagnosis and treatment of breast cancer: a multinational analysisJassem, Jacek; Ozmen, Vahit; Bacanu, Florin; Drobniene, Monika; Eglitis, Janis; Lakshmaiah, Kuntegowdanahalli C.; Kahan, Zsuzsanna; Mardiak, Jozef; Pienkowski, Tadeusz; Semiglazova, Tatiana; Stamatovic, Ljiljana; Timcheva, Constanta; Vasovic, Suzana; Vrbanec, Damir; Zaborek, Piotr 分享 收藏 First-line bevacizumab (BEV) plus chemotherapy for hormone receptor-positive metastatic breast cancer (mBC): Subgroup analysis of the open-label non-inferiority TURANDOT phase III trial.Kahan, Zsuzsanna; Petruzelka, Lubos; Eniu, Alexandru; Anghel, Rodica; Koynov, Krassimir; Vrbanec, Damir; Lang, Istvan; Ahlers, Silke; Brodowicz, Thomas; Zielinski, Christoph 分享 收藏 Heterozygous Carriage of a Dysfunctional Toll-like Receptor 9 Allele Affects CpG Oligonucleotide Responses in B CellsKnezevic, Jelena; Pavlinic, Dinko; Rose, William A., II; Leifer, Cynthia A.; Bendelja, Kreso; Gabrilovac, Jelka; Parcina, Marijo; Lauc, Gordan; Kubarenko, Andriy V.; Petricevic, Branka; Vrbanec, Damir; Bulat-Kardum, Ljiljana; Bekeredjian-Ding, Isabelle; Pavelic, Jasminka; Dembic, Zlatko; Weber, Alexander N. R. 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
